Epithelial-to-mesenchymal transition is a resistance mechanism to sequential MET-TKI treatment of MET-amplified EGFR-TKI resistant non-small cell lung cancer cells.
Saved in:
| Title: | Epithelial-to-mesenchymal transition is a resistance mechanism to sequential MET-TKI treatment of MET-amplified EGFR-TKI resistant non-small cell lung cancer cells. |
|---|---|
| Authors: | Clement MS; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark., Gammelgaard KR; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Nielsen AL; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Sorensen BS; Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark. |
| Source: | Translational lung cancer research [Transl Lung Cancer Res] 2020 Oct; Vol. 9 (5), pp. 1904-1914. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101646875 Publication Model: Print Cited Medium: Print ISSN: 2218-6751 (Print) Linking ISSN: 22186751 NLM ISO Abbreviation: Transl Lung Cancer Res Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2218-6751 |
|---|---|
| DOI: | 10.21037/tlcr-20-522 |
